+454.2%
MRNA vs IP
-23.5%
+477.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | IP | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -5.1% | +1.7% | -1.1% |
| 7D | -10.1% | -4.6% | -5.5% | -8.2% |
| 30D | +126.7% | -15.3% | +142.0% | +144.7% |
| 3M | +184.1% | +2.7% | +181.4% | +195.9% |
| 6M | +143.3% | -7.4% | +150.7% | +155.4% |
| YTD | +359.9% | -8.8% | +368.7% | +381.2% |
| 1Y | +454.2% | -22.4% | +476.6% | +473.2% |
| All | +454.2% | -23.5% | +477.7% | +473.2% |
Cumulative growth
Daily Returns
Daily percentage return beside IP.
Daily Out/Under-Performance
Portfolio return minus IP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × IP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded IP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling